Jefferies Bullish on 6 Healthcare Stocks with Up to 46% Upside
Jefferies remains positive on six healthcare stocks despite recent losses due to regulatory scrutiny on cancer-drug markups and pharmacy practices. The firm maintains Buy ratings, forecasting target-price gains between 22% and 46%, supported by strong projected EBITDA growth through fiscal year 2029.
ET Markets·




